CAVU is a Delaware C-corp that is modernizing cancer care for our dogs through patent-pending personalized immunotherapies. Our mission is to keep pet families intact longer. We provide vet oncologists & primary vets services such as Autologous Prescription Product, Cryobanking, and Immune Health Panels. We are USDA authorized & are generating revenue from clinics in 9 states. The vet cancer market is over $700M w/ 4M to 6M new cancer cases/yr.